Vaxerna Limited
Records under this name other than the patents Vaxerna Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 3 of 3 · Back to Vaxerna Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,744,222 | Peptide for Vaccine Lapsed on the fee record Ended Aug 29, 2025 · High confidence | Lapsed on the fee record | Ended Aug 29, 2025 | High confidence |
| US 9,657,061 | Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy Lapsed on the fee record Ended May 23, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 23, 2025 | From the USPTO record |
| US 9,347,937 | Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy Lapsed on the fee record Ended May 24, 2024 · From the USPTO record | Lapsed on the fee record | Ended May 24, 2024 | From the USPTO record |